✉  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Peripheral Artery Disease Market Research Report Information By Treatment Type (Device, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Others), By Drugs (Lipid Lowering Drugs, Triple-H Therapy, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytic Agents, and Anti-Inflammatory Agents), By End User (Hospitals & Clinics, and Ambulatory Surgical Clinics) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/MED/1011-CR | 137 Pages | Author: Kinjoll Dey| February 2020

Peripheral Artery Disease Market Segmentation


Peripheral Artery Disease Treatment Type Outlook (USD Billion, 2018-2032)




  • Device




  • Catheters




  • Plaque Modification Devices




  • Hemodynamic Flow Alteration Devices




  • Others




Peripheral Artery Disease Drugs Outlook (USD Billion, 2018-2032)




  • Lipid Lowering Drugs




  • Triple-H Therapy




  • Glucose Regulating Drugs




  • Blood Clot Preventing Drugs




  • Inotropes




  • Thrombolytic Agents




  • Anti-Inflammatory Agents




Peripheral Artery Disease End User Outlook (USD Billion, 2018-2032)




  • Hospitals & Clinics




  • Ambulatory Surgical Clinics




Peripheral Artery Disease Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • North America Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs, Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • North America Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • US Outlook (USD Billion, 2018-2032)




    • US Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • US Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • US Peripheral Artery Disease by End User




      • Hospitals & Drugs




      • Ambulatory Surgical Clinics






    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • CANADA Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • CANADA Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • Europe Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • Europe Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • Germany Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • Germany Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • France Outlook (USD Billion, 2018-2032)




    • France Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • France Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • France Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • UK Outlook (USD Billion, 2018-2032)




    • UK Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • UK Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • UK Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • ITALY Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • ITALY Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • Spain Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • Spain Peripheral Artery Disease by End User




      • Hospitals & Drugs




      • Ambulatory Surgical Clinics






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • REST OF EUROPE Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • REST OF EUROPE Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • Asia-Pacific Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • Asia-Pacific Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • China Outlook (USD Billion, 2018-2032)




    • China Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • China Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • China Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • Japan Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • Japan Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • India Outlook (USD Billion, 2018-2032)




    • India Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • India Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • India Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • Australia Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • Australia Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • Rest of Asia-Pacific Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • Rest of Asia-Pacific Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • Rest of the World Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • Rest of the World Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • Middle East Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • Middle East Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • Africa Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • Africa Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Peripheral Artery Disease by Treatment Type




      • Device




      • Catheters




      • Plaque Modification Devices,




      • Hemodynamic Flow Alteration Devices




      • Others






    • Latin America Peripheral Artery Disease by Drugs




      • Lipid Lowering Drugs




      • Triple-H Therapy




      • Glucose Regulating Drugs




      • Blood Clot Preventing Drugs,




      • Inotropes,




      • Thrombolytic Agents,




      • Anti-Inflammatory Agents






    • Latin America Peripheral Artery Disease by End User




      • Hospitals & Clinics




      • Ambulatory Surgical Clinics







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 EXECUTIVE SUMMARY

1.1 OVERVIEW 15

1.1.1 MARKET SYNOPSIS 15

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 16

2.2 RESEARCH OBJECTIVE 16

2.3 LIST OF ASSUMPTIONS 16

3 RESEARCH METHODOLOGY

3.1.1 OVERVIEW 18

3.2 DATA MINING 18

3.3 SECONDARY RESEARCH 19

3.4 PRIMARY RESEARCH 20

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 21

3.5 FORECASTING TECHNIQUES 21

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22

3.6.1 BOTTOM-UP APPROACH 23

3.6.2 TOP-DOWN APPROACH 24

3.7 DATA TRIANGULATION 24

3.8 VALIDATION 24

4 MARKET DYNAMICS

4.1 OVERVIEW 25

4.2 DRIVERS 26

4.2.1 RISING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN THE PREVALENCE OF

PERIPHERAL ARTERY DISEASES 26

4.2.2 PRODUCT LAUNCH AND TECHNOLOGICAL ADVANCEMENT 26

4.2.3 INCREASING CASES OF DIABETES 27

4.2.4 DRIVERS IMPACT ANALYSIS 27

4.3 RESTRAINTS 28

4.3.1 PRODUCT RECALLS 28

4.3.2 RESTRAINTS IMPACT ANALYSIS 28

4.4 OPPORTUNITIES 28

4.4.1 ENTRY OF MARKET PLAYERS INTO EMERGING ECONOMIES 28

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 29

5.1.1 THREAT OF NEW ENTRANTS 30

5.1.2 BARGAINING POWER OF SUPPLIERS 30

5.1.3 THREAT OF SUBSTITUTES 30

5.1.4 BARGAINING POWER OF BUYERS 30

5.1.5 INTENSITY OF RIVALRY 30

5.2 VALUE CHAIN ANALYSIS 31

5.2.1 R&D AND DESIGNING 32

5.2.2 MANUFACTURING 32

5.2.3 DISTRIBUTION 32

5.2.4 MARKETING & SALES 32

5.2.5 POST-SALES MONITORING 32

6 PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

6.1 OVERVIEW 33

6.2 DEVICES 34

6.2.1 ANGIOPLASTY BALLOON 36

6.2.2 ANGIOPLASTY STENTS (STENTING) 37

6.2.3 CATHETERS 37

6.2.4 PLAQUE MODIFICATION DEVICES (ATHERECTOMY) 38

6.2.5 HEMODYNAMIC FLOW ALTERATION DEVICES 38

6.3 DRUGS 39

6.3.1 LIPID-LOWERING DRUGS 40

6.3.2 BLOOD PRESSURE LOWERING DRUGS 41

6.3.3 GLUCOSE REGULATING DRUGS 41

6.3.4 BLOOD CLOT PREVENTING DRUGS 42

7 PERIPHERAL ARTERY DISEASE MARKET, BY END USER

7.1 OVERVIEW 43

7.1.1 HOSPITALS AND CLINICS 45

7.1.2 AMBULATORY SURGERY CENTERS 45

8 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY REGION

8.1 OVERVIEW 46

8.2 AMERICAS 47

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.2.1 NORTH AMERICA 50

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.2.1.1 US 53

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.2.1.2 CANADA 55

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.2.2 LATIN AMERICA 57

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.3 EUROPE 59

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.3.1 WESTERN EUROPE 62

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.3.1.1 GERMANY 66

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.3.1.2 FRANCE 68

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.3.1.3 UK 70

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.3.1.4 ITALY 72

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.3.1.5 SPAIN 74

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.3.1.6 REST OF WESTERN EUROPE 76

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.3.2 EASTERN EUROPE 78

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.4 ASIA-PACIFIC 80

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.4.1 CHINA 83

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.4.2 JAPAN 85

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.4.3 INDIA 87

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.4.4 AUSTRALIA 89

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.4.5 SOUTH KOREA 91

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.4.6 REST OF ASIA-PACIFIC 93

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.5 MIDDLE EAST & AFRICA 95

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.5.1 MIDDLE EAST 99

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

8.5.2 AFRICA 101

PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE

PERIPHERAL ARTERY DISEASE MARKET, BY END USER

9 COMPETITIVE LANDSCAPE: GLOBAL PERIPHERAL ARTERY DISEASE MARKET

9.1 OVERVIEW 103

9.2 COMPETITIVE ANALYSIS 103

10 COMPANY PROFILES

10.1 KONINKLIJKE PHILIPS NV 104

10.1.1 COMPANY OVERVIEW 104

10.1.2 FINANCIAL OVERVIEW 105

10.1.3 PRODUCTS/SERVICES OFFERED 106

10.1.4 KEY DEVELOPMENTS 106

10.1.5 SWOT ANALYSIS 107

10.1.6 KEY STRATEGIES 107

10.2 B. BRAUN MELSUNGEN AG 108

10.2.1 COMPANY OVERVIEW 108

10.2.2 FINANCIAL OVERVIEW 109

10.2.3 PRODUCTS/SERVICES OFFERED 109

10.2.4 KEY DEVELOPMENTS 110

10.2.5 SWOT ANALYSIS 110

10.2.6 KEY STRATEGIES 110

10.3 COOK 111

10.3.1 COMPANY OVERVIEW 111

10.3.2 FINANCIAL OVERVIEW 111

10.3.3 PRODUCTS/SERVICES OFFERED 111

10.3.4 KEY DEVELOPMENTS 111

10.3.5 SWOT ANALYSIS 112

10.3.6 KEY STRATEGIES 112

10.4 MEDTRONIC 113

10.4.1 COMPANY OVERVIEW 113

10.4.2 FINANCIAL OVERVIEW 114

10.4.3 PRODUCTS/SERVICES OFFERED 115

10.4.4 MEDTRONIC: KEY DEVELOPMENTS 115

10.4.5 SWOT ANALYSIS 116

10.4.6 KEY STRATEGIES 116

10.5 BAYER AG 117

10.5.1 COMPANY OVERVIEW 117

10.5.2 FINANCIAL OVERVIEW 118

10.5.3 PRODUCTS/SERVICES OFFERED 118

10.5.4 KEY DEVELOPMENTS 119

10.5.5 SWOT ANALYSIS 119

10.5.6 KEY STRATEGIES 119

10.6 BOSTON SCIENTIFIC CORPORATION 120

10.6.1 COMPANY OVERVIEW 120

10.6.2 FINANCIAL OVERVIEW 121

10.6.3 PRODUCTS/SERVICES OFFERED 122

10.6.4 KEY DEVELOPMENTS 122

10.6.5 SWOT ANALYSIS 123

10.6.6 KEY STRATEGIES 123

10.7 BECTON, DICKINSON AND COMPANY 124

10.7.1 COMPANY OVERVIEW 124

10.7.2 FINANCIAL OVERVIEW 125

10.7.3 PRODUCTS/SERVICES OFFERED 125

10.7.4 KEY DEVELOPMENTS 126

10.7.5 SWOT ANALYSIS 126

10.7.6 KEY STRATEGIES 126

10.8 TERUMO MEDICAL CORPORATION 127

10.8.1 COMPANY OVERVIEW 127

10.8.2 FINANCIAL OVERVIEW 128

10.8.3 PRODUCTS OFFERED 128

10.8.4 KEY DEVELOPMENTS 129

10.8.5 SWOT ANALYSIS 129

10.8.6 KEY STRATEGIES 129

10.9 BIOTRONIK 130

10.9.1 COMPANY OVERVIEW 130

10.9.2 FINANCIAL OVERVIEW 130

10.9.3 PRODUCTS OFFERED 130

10.9.4 KEY DEVELOPMENTS 131

10.9.5 SWOT ANALYSIS 132

10.9.6 KEY STRATEGIES 132

10.10 CARDINAL HEALTH 133

10.10.1 COMPANY OVERVIEW 133

10.10.2 FINANCIAL OVERVIEW 134

10.10.3 PRODUCTS OFFERED 135

10.10.4 KEY DEVELOPMENTS 135

10.10.5 SWOT ANALYSIS 136

10.10.6 KEY STRATEGIES 136

11 APPENDIX

11.1 REFERENCES 137

11.2 RELATED REPORTS 137

12 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 16

TABLE 2 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 34

TABLE 3 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 36

TABLE 4 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR ANGIOPLASTY BALLOON, BY REGION, 2023-2032 (USD MILLION) 36

TABLE 5 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR ANGIOPLASTY STENTS (STENTING), BY REGION,

2023-2032 (USD MILLION) 37

TABLE 6 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR CATHETERS, BY REGION, 2023-2032 (USD MILLION) 37

TABLE 7 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR PLAQUE MODIFICATION DEVICES (ATHERECTOMY), BY REGION,

2023-2032 (USD MILLION) 38

TABLE 8 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION,

2023-2032 (USD MILLION) 38

TABLE 9 GLOBAL PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 40

TABLE 10 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR LIPID-LOWERING DRUGS, BY REGION, 2023-2032 (USD MILLION) 40

TABLE 11 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR BLOOD PRESSURE LOWERING DRUGS, BY REGION,

2023-2032 (USD MILLION) 41

TABLE 12 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR GLUCOSE REGULATING DRUGS, BY REGION, 2023-2032 (USD MILLION) 41

TABLE 13 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR BLOOD CLOT PREVENTING DRUGS, BY REGION,

2023-2032 (USD MILLION) 42

TABLE 14 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 44

TABLE 15 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2023-2032 (USD MILLION) 45

TABLE 16 GLOBAL PERIPHERAL ARTERY DISEASE MARKET FOR AMBULATORY SURGERY CENTERS, BY END USER,

2023-2032 (USD MILLION) 45

TABLE 17 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 47

TABLE 18 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 48

TABLE 19 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 48

TABLE 20 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 49

TABLE 21 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 49

TABLE 22 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 50

TABLE 23 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 51

TABLE 24 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 51

TABLE 25 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 52

TABLE 26 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 52

TABLE 27 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 53

TABLE 28 US: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 53

TABLE 29 US: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 54

TABLE 30 US: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 54

TABLE 31 US: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 55

TABLE 32 CANADA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 55

TABLE 33 CANADA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 56

TABLE 34 CANADA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 56

TABLE 35 CANADA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 57

TABLE 36 LATIN AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 57

TABLE 37 LATIN AMERICA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 58

TABLE 38 LATIN AMERICA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 58

TABLE 39 LATIN AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 59

TABLE 40 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 60

TABLE 41 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 60

TABLE 42 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 61

TABLE 43 EUROPE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 61

TABLE 44 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 62

TABLE 45 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 63

TABLE 46 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 64

TABLE 47 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 64

TABLE 48 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 65

TABLE 49 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 65

TABLE 50 GERMANY: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 66

TABLE 51 GERMANY: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 66

TABLE 52 GERMANY: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 67

TABLE 53 GERMANY: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 67

TABLE 54 FRANCE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 68

TABLE 55 FRANCE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 68

TABLE 56 FRANCE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 69

TABLE 57 FRANCE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 69

TABLE 58 UK: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 70

TABLE 59 UK: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 70

TABLE 60 UK: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 71

TABLE 61 UK: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 71

TABLE 62 ITALY: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 72

TABLE 63 ITALY: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 72

TABLE 64 ITALY: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 73

TABLE 65 ITALY: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 73

TABLE 66 SPAIN: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 74

TABLE 67 SPAIN: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 74

TABLE 68 SPAIN: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 75

TABLE 69 SPAIN: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 75

TABLE 70 REST OF WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 76

TABLE 71 REST OF WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 76

TABLE 72 REST OF WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 77

TABLE 73 REST OF WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 77

TABLE 74 EASTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 78

TABLE 75 EASTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 78

TABLE 76 EASTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 79

TABLE 77 EASTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 79

TABLE 78 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 81

TABLE 79 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 81

TABLE 80 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 82

TABLE 81 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 82

TABLE 82 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 83

TABLE 83 CHINA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 83

TABLE 84 CHINA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 84

TABLE 85 CHINA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 84

TABLE 86 CHINA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 85

TABLE 87 JAPAN: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 85

TABLE 88 JAPAN: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 86

TABLE 89 JAPAN: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 86

TABLE 90 JAPAN: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 87

TABLE 91 INDIA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 87

TABLE 92 INDIA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 88

TABLE 93 INDIA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 88

TABLE 94 INDIA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 89

TABLE 95 AUSTRALIA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 89

TABLE 96 AUSTRALIA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 90

TABLE 97 AUSTRALIA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 90

TABLE 98 AUSTRALIA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 91

TABLE 99 SOUTH KOREA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 91

TABLE 100 SOUTH KOREA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 92

TABLE 101 SOUTH KOREA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 92

TABLE 102 SOUTH KOREA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 93

TABLE 103 REST OF ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 93

TABLE 104 REST OF ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 94

TABLE 105 REST OF ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 94

TABLE 106 REST OF ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 95

TABLE 107 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 96

TABLE 108 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 97

TABLE 109 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 97

TABLE 110 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 98

TABLE 111 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 98

TABLE 112 MIDDLE EAST: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 99

TABLE 113 MIDDLE EAST: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 99

TABLE 114 MIDDLE EAST: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 100

TABLE 115 MIDDLE EAST: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 100

TABLE 116 AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 101

TABLE 117 AFRICA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 101

TABLE 118 AFRICA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 102

TABLE 119 AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 102

TABLE 120 KONINKLIJKE PHILIPS NV: PRODUCTS/SERVICES OFFERED 106

TABLE 121 KONINKLIJKE PHILIPS NV: KEY DEVELOPMENTS 106

TABLE 122 B. BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED 109

TABLE 123 B. BRAUN MELSUNGEN AG: KEY DEVELOPMENTS 110

TABLE 124 COOK: PRODUCTS/SERVICES OFFERED 111

TABLE 125 COOK: KEY DEVELOPMENTS 111

TABLE 126 MEDTRONIC: PRODUCTS/SERVICES OFFERED 115

TABLE 127 KEY DEVELOPMENTS 115

TABLE 128 BAYER AG: PRODUCTS/SERVICES OFFERED 118

TABLE 129 BAYER AG: KEY DEVELOPMENTS 119

TABLE 130 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED 122

TABLE 131 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES OFFERED 125

TABLE 132 BECTON, DICKINSON AND COMPANY: KEY DEVELOPMENTS 126

TABLE 133 TERUMO MEDICAL CORPORATION: PRODUCTS OFFERED 128

TABLE 134 TERUMO MEDICAL CORPORATION: KEY DEVELOPMENTS 129

TABLE 135 BIOTRONIK: PRODUCTS OFFERED 130

TABLE 136 BIOTRONIK: KEY DEVELOPMENTS 131

TABLE 137 CARDINAL HEALTH: PRODUCTS OFFERED 135

TABLE 138 CARDINAL HEALTH: KEY DEVELOPMENTS 135

13 LIST OF FIGURES

FIGURE 1 GLOBAL PERIPHERAL ARTERY DISEASE MARKET STRUCTURE 17

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 23

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PERIPHERAL ARTERY DISEASE MARKET 25

FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PERIPHERAL ARTERY DISEASE MARKET 29

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL PERIPHERAL ARTERY DISEASE MARKET 31

FIGURE 6 GLOBAL PERIPHERAL ARTERY DISEASE MARKET SHARE, BY TREATMENT TYPE, 2020 (%) 33

FIGURE 7 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 34

FIGURE 8 GLOBAL PERIPHERAL ARTERY DISEASE MARKET FOR DEVICES, BY TYPE, 2023-2032 (USD MILLION) 35

FIGURE 9 GLOBAL PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2023-2032 (USD MILLION) 39

FIGURE 10 GLOBAL PERIPHERAL ARTERY DISEASE MARKET SHARE, BY END USER, 2020 (%) 43

FIGURE 11 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2023-2032 (USD MILLION) 44

FIGURE 12 GLOBAL PERIPHERAL ARTERY DISEASE MARKET SHARE, BY REGION, 2020 (%) 46

FIGURE 13 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 46

FIGURE 14 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 47

FIGURE 15 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 48

FIGURE 16 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 50

FIGURE 17 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 51

FIGURE 18 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 59

FIGURE 19 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 60

FIGURE 20 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 62

FIGURE 21 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 63

FIGURE 22 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 80

FIGURE 23 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 80

FIGURE 24 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 95

FIGURE 25 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2023-2032 (USD MILLION) 96

FIGURE 26 GLOBAL: MARKET SHARE OF MAJIOUR COMPETITORS, 2020 (%) 103

FIGURE 27 KONINKLIJKE PHILIPS NV: FINANCIAL OVERVIEW SNAPSHOT 105

FIGURE 28 KONINKLIJKE PHILIPS NV: SWOT ANALYSIS 107

FIGURE 29 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW 109

FIGURE 30 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS 110

FIGURE 31 COOK: SWOT ANALYSIS 112

FIGURE 32 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT 114

FIGURE 33 MEDTRONIC: SWOT ANALYSIS 116

FIGURE 34 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT 118

FIGURE 35 BAYER AG: SWOT ANALYSIS 119

FIGURE 36 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 121

FIGURE 37 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS 123

FIGURE 38 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT 125

FIGURE 39 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS 126

FIGURE 40 TERUMO MEDICAL CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 128

FIGURE 41 TERUMO MEDICAL CORPORATION: SWOT ANALYSIS 129

FIGURE 42 BIOTRONIK: SWOT ANALYSIS 132

FIGURE 43 CARDIAC HEALTH: FINANCIAL OVERVIEW SNAPSHOT 134

FIGURE 44 CARDINAL HEALTH: SWOT ANALYSIS 136

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Related Reports
report-img
Angioplasty Balloons Market Research Report - Forecast till 2032
report-img
Therapeutic Medical Guidewire Market Research Report - Forecast till 2030
report-img
LDL Test Market Research Report- Global Forecast Till 2030
report-img
PTA Balloon Catheters Devices Market Research Report — Global Forecast till 2032
Press Release
pr-img
Peripheral Artery Disease Market Outlook and Opportunities in Grooming Regions with Forecast 2032
Logo
Dmca Cloudflare ssl
Paypal footer Ssl
Services Industry Expertise Consulting Services Articles How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners
Amex Mastercard1
Razerpay
Hdfcbank
Visa
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)